Endovascular neurosurgery is an evolving field, with the goal of treating neurological disease with minimal invasion of the body. The current approach is to deliver focused therapies via catheters traveling through the vascular tree. Refinement and advancement of these techniques requires not just new ideas, but new ideas that hold up when tested through the scientific method.
Introduction
Endovascular neurosurgery is an evolving field, with the goal of treating neurological disease with minimal invasion of the body. The current approach is to deliver focused therapies via catheters traveling through the vascular tree. Refinement and advancement of these techniques requires not just new ideas, but new ideas that hold up when tested through the scientific method.
Before clinical trials can begin, ethics and law demand that the ideas are tested first under experimental models. One benefit of these pre-clinical tests is the early identification of side effects. Another is the opportunity to practice and polish surgical technique in advance of human surgery.
Historically, the best models of human systems have been similar systems in appropriate animals. Like human care, animal use is governed by strict laws and regulations. Violating these rules can not only result in criminal penalties, they can also make the research worthless: an animal poorly cared for may have physical symptoms that mask or confound the response to treatment.
As computing power has increased, mathematical models have become more popular. The advantages of computational models include relative costs and relative speed. No animals, drugs or equipment have to be purchased, just a computer and software. The disadvantage is that the computational model can only represent those aspects of the modeled system that are understood and quantifiable.
This article is an overview of how both animal and computational models have been used to approximate neurovascular conditions by researchers seeking to explore treatment options.
Animal Models
Aneurysm Dog A common animal model for aneurysms is the canine, in which aneurysms are surgically constructed most often through the use of venous pouches. This model was first used in 1954 by German and Black 1 . Shin and Niimi later revised it 2 to allow the creation of four kinds of aneurysm-bifurcation, side-wall, arterial stump and small branch, each with different hemodynamics-in one dog. The canine models have been consistently used due to their ease of handling and anesthesia, the similarity of the blood vessel size to that in humans, and the reproducibility of the studies. However, the canine has a tendency toward rapid lysis of clots, which limits its validity as a model for testing thrombosis of aneurysms after embolization 3, 4 Rabbit A rabbit model of bifurcation aneurysms has been described by Spetzger and Reul. 5 Although the rabbit has a similar blood clotting system to that of the human-an advantage missing in the dogthis model was limited due to high rates of pneumonia, post-operative neurologic complications, and peri-and post-operative mortality. There was also a high likelihood of inadvertent vessel occlusion seen on angiography after creation of the aneurysms. Only about half of the procedures yielded surgically created aneurysms which could be treated by coil embolization.
Pig
Venous pouch aneurysms have also been created on the common carotid artery in swine 6 An advantage of the swine model is that spontaneous rupture of aneurysms, like those seen in humans, can occur 7 ; experimental aneurysms in other animal models do not tend to rupture spontaneously. To construct the model, an anastomosis is created between the common carotid artery and the external jugluar vein. Retaining sutures are used to create a pouch in the proximal draining external jugular vein. After the animal heals for one to two weeks, an endovascular balloon can be placed angiographically to close the fistula, thus creating a fusiform vein pouch aneurysm which can subsequently be used for testing embolization devices.
Rat
Rats are popular in research for simple economic reasons: they are cheap to purchase and cheap to house. Many experimental studies require a comparison of treatments in several subjects; a large number of dogs or pigs would be prohibitively costly, and we have already seen that rabbits had a poor experimental yield. In a study of twenty rats, ten receiving Gugliemi detachable coils and ten receiving biodegradable polyglycolide coils 8 , the aneurysms were created by permanent occlusion of the common carotid artery (CCA) just proximal to its bifurcation, creating an arteriotomy between the two ligatures and directly depositing segments of coils into the CCA. Although this model was useful to test the response of arteries to the deposited segments of coils, it was 
Figure 1
Canine aneurysm model limited because the end-artery did not have flow or anatomical characteristics similar to aneurysms. Vein-pouch aneurysm models have also been described in rats.
9,10
Monkey Because monkeys are so closely related to humans, they would be considered the most accurate model for most systems. In an effort to more closely mimic the anatomy and hematologic clotting characteristics of the human, Tenjin and Ueda developed a primate aneurysm model. 11 They used femoral vein pouches to create venous pouch aneurysms bilaterally on the carotid arteries of Japanese monkeys. They noted a success rate of 74% at two weeks in creating their aneurysms.
Arteriovenous Malformations (AVMs)

Pig
Pig vessels approximate the size of human vessels, their coagulation profile is similar to that in the human and they are fairly simple to anaesthetize. With these advantages, the pig model is the most commonly used and described model of cerebral AVMs. The swine, and other mammals including sheep, goat, ox and cat, provide blood supply to the brain via an arterial network of vessels, known as the rete mirabile, which is surrounded by the cavernous sinus at the base of the brain. Because the rete mirabile is a purely arterial network (as seen in other mammals including sheep, goat, ox and cat), a valid AVM model is created as an arterio-venous fistula formed by isolating and anastomosing the external jugular vein and common carotid artery on one side of the neck.
3, 4 The creation of this fistula with occlusion of carotid artery branches has been shown to increase flow and pressures across the rete [12] [13] [14] and result in histologic changes to vessel walls very similar to those seen in human cerebral AVMs. 15 This model has been used repeatedly for training in endovascular techniques, to evaluate nascent embolic materials and for histologic evaluations of radiosurgical induced changes.
16,17
Dog
The only canine AVM model described is also the only completely intracerebral AVM model. Pietilä et al. 18 created an arteriovenous fistula (AVF) by interposing a segment of superficial temporal artery between a main branch of the middle cerebral artery and the sagittal sinus. They concurrently implanted a muscle graft supplied by a branch of the fistula onto the ischemic area of the brain. Their intent was to have the ischemia serve as an angiogenic stimulus and thus mimic the angiogenesis that occurs in human AVMs. The authors found that many other aspects of this model mimicked human AVMs, including: thickening and fibrosis of the wall of the draining vein; angiogenesis surrounding the area of the created AVM with new vessels demonstrating pathological wall changes; gliotic brain tissue formation and areas of ischemia; hemorrhage and thrombus formation in the brain tissue and vessels surrounding the created nidus. The authors did not however, report any attempts at experimental treatments of this model.
Rat
In the rat, Bederson 19 created an extracranial arteriovenous fistula with occlusion of the contralateral vein. This was first created in an attempt to determine if a dural AVM would form as a result of sinus thrombosis. This model has been further modified to evaluate cerebral hypoperfusion 20 , the role of radiotherapy in the treatment of AVFs/AVMs 21 , and the role of sinus hypertension and thrombosis in the development of dural AVMs.
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Vasospasm Cerebral vasospasm continues to be one of the major causes of morbidity and mortality following anuerysmal subarachnoid hemorrhage. Megyesi et al. published a review of fifty-seven in vivo animal models of cerebral vasospasm dating back to 1928. 23 These models employed rats, rabbits, cats, pigs, canines and primates. 72% used a technique in which blood was instilled around blood vessels to cause vasospasm and the remainder used a technique whereby they punctured or lacerated a vessel to allow blood to escape and thus induce vasospasm. Some of these models involve open cranial surgery to puncture the vessels, while others have implemented perforating the vessel from the luminal side by using an endovascular approach. They also describe extracranial models of vasospasm although they do point out that these models are controversial because their validity is questionable.
Simulations
Aneurysm
In a joint project between the departments of Neurosurgery and Aerospace Engineering, Kim et al. 24 used a computational fluid dynamics software package to assess the risk of aneurysm rupture when porous stents were used as the sole treatment. Such models are reliable to the point where they can predict angiograms. 25 A model of a wide-necked basilar trunk aneurysm was constructed based on the patient's CT scans. The aneurysm was modeled untreated and treated with 1-3 stents from various manufacturers. The model predicted that these stents could suppress complex blood flow associated with ruptured aneurysms in another simulation study 26 , although the size of the effect depended on the specific geometry and on how well the stents were deployed and that a single stent would probably be insufficient to ensure a good outcome.
Arteriovenous Malformations (AVMs)
Hademenos and Massoud created a mathematical model based on electrical networks. 27, 28 This model was designed to allow an analysis of changes in AVM hemodynamic and biophysical characteristics, and individual parameters could be manipulated to determine changes in flow characteristic and likelihood of rupture or hemorrhage after various treatments.
Kerber and Hecht 29 implemented on a personal computer (with an Intel 286 microprocessor!) a mathematical model which represented the AVM as a collection of 1000 channels, each of which must be embolized to "cure" the simulated AVM. They later 30 constructed a physical model from a sponge with waxed tubes representing inflow (arterial feeders) and outflow tracts (draining veins). These models were intended to help guide the development of new neurointerventional techniques. The physical model made it further possible to test liquid embolic materials using microcatheters, and to teach endovascular embolization techniques in a no-risk situation. 
Applications in Training
In an ongoing effort to promote patient safety and enhance skills training, recent advances in technology have contributed to the development of non-animal simulation technology. These simulators enhance learning fundamental skills in procedures such as basic suturing, laparscopic surgery and endovascular treatments. As the technologies improve, the fidelity of these models has improved the reliability of these systems. For example, Wong et al.
31 describe a 3D virtual reality system integrated with simulated manipulators for training in craniotomies and aneurysm clipping. A variety of clips and patient aneurysms were scanned into the simulator database so the user could learn how and why to combine different clips with different surgical approaches. Another group 32,33 used the same system to train clinicians in minimally invasive surgical techniques.
The development of haptic technologies, which provide touch and pressure feedback, have significantly improved the tactile experience of simulators. 34, 35 Currently in use at the Jefferson Hospital for Neuroscience (JHN) is the Procedicus VIST™ simulator. This is a virtual reality simulator system that uses haptic feedback and metric assessment. 36, 37 It can be used to acquire and hone basic and complex neuroendovascular skills. The system utilizes a mannequin and two computer screens along with actual endovascular equipment. The computer allows the user to choose from a variety of different programs representing different pathologies, e.g. saccular aneurysms, fusiform aneurysms, carotid stenosis.
The simulator at JHN has been used by neurointerventional technologists, residents and fellows to develop proficiency in various procedures. This leads to increased benefits for practitioners, as they have improved skills and confidence when performing procedures on patients. The simulator has also improved patient safety as simulators have been shown to improve performance in endovascular procedures.
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Conclusion
The new era of evidence-based management of disease will continue to demand increased justification from physicians for the treatments they use. At the same time, ethical constraints limit the early testing of new technologies on patients. Animal models, when designed, validated and used appropriately, can be an invaluable resource in the development of lifesaving technologies and techniques. One reason to model a biological system is that construction of the model proves enough understanding to reproduce the system. It is presumably that same understanding that makes neurosurgical repair of the patient possible. A potential advantage of computational models is the opportunity to perform many virtual experiments in less time than it would take to perform one real experiment, but this depends on the power of the computer relative to the complexity of the model. An extension of this is using a computer to design optimized surgical plans and project the likely outcomes for patients in advance of surgery. The potential of computer models is restricted by the bottom limit of our ability to observe physiological processes and represent them on computer: as yet, we may not even have approached that limit. 
Introduction
Spinal cord stimulation (SCS) is an adjustable, non-destructive procedure which delivers therapeutic doses of electrical current to the spinal cord for the management of neuropathic pain. The most common indications include post-laminectomy ("failed back surgery") syndrome, complex regional pain syndrome (CRPS), ischemic limb pain, and angina. Other reported applications include visceral/abdominal pain, cervical neuritis pain, spinal cord injury pain, post-herpetic neuralgia, and neurogenic thoracic outlet syndrome.
History
Advances in technology have driven the popularity of the field. Initially, the contact combinations could only be hardwired, and could not be reprogrammed after the pulse generator was implanted. In the beginning, only radio-frequency (RF) driven passive receivers were available. In the midseventies, the first implantable pulse generator powered by a lithium battery was introduced into the market. In 1980, the first percutaneous electrode was produced, and this could be reprogrammed non-invasively through an external transmitter. 
Mechanisms of Action
SCS began when Melzack and Wall
2 noted that stimulation of large peripheral nerve fibers could block the sensation of pain. In 1967, Shealy 3 inserted the first dorsal column stimulator in a human suffering from terminal metastatic cancer. Later approaches implanted electrodes via a laminectomy in the subarachnoid space, between the two layers of the dura, or in the epidural space. [4] [5] [6] Subsequently, less invasive percutaneous techniques were introduced.
7
The exact mechanisms of action of SCS remain unclear, although computer modeling work has shed some light on the distribution of complex electrical fields within the spine. [8] [9] [10] [11] [12] [13] Animal studies suggest that the SCS triggers the release of serotonin, substance P, and GABA within the dorsal horn.
14, 15 It is not known whether stimulation of different sites-peripheral nerves, dorsal columns, or supra-lemniscal pathways-will trigger equivalent mechanisms of action.
Indications
SCS has been successfully used for a variety of pain conditions (Table I) . Experience suggests that, in selected patients, SCS can produce at least 50% pain relief in 50-60% of the implanted patients. Interestingly, with the proper follow-up care, these results can be maintained over several years.
Complex Regional Pain Syndrome (CRPS)
The implementation of SCS in individuals with CRPS type I is more difficult than with any other patients groups. There is risk of aggravating the original pain or causing a new pain at the implanted hardware site is greater than with any other diagnostic category mentioned. The CPRS-affected areas may be too widespread for effective stimulation.
In 1989, Barolat et al. reported reduction of pain in ten out of thirteen patients implanted. No patients in that series were made pain free but all ten reported a definite difference from stimulation. 16 In 1997, Kumar et al. reported on twelve patients with permanently implanted leads 17 : eight patients enjoyed near complete resolution of their symptoms and four also maintained good relief.
Kemler et al. reported 23 additional cases with 78% of the patients reporting improvement.
18 A later study 19 compared patients randomized to SCS to those treated with physical therapy. In the SCS group, 67% of patients experienced significant pain relief which persisted at 6 months. However, no functional improvement was observed in either group. A 5-year follow-up on the SCS group indicated that the effects of SCS diminished over time for these patients.
20
Oakley and Weiner reported a prospective study of 19 patients with CRPS implanted with spinal cord stimulation systems. 21 Of the ten patients in whom detailed long-term efficacy data was available, three reported full relief from their pain and seven, partial beneficial relief.
Three additional prospective studies without matched controls have been reported. [21] [22] [23] Two of the studies reported success rates with an 84% overall success rate. The third study by Calvillo et al. 22 reported a significant improvement in pain scores and a >50% reduction in narcotic use by 44% of subjects. In eight retrospective studies the overall success rate was 84% 192 patients.
24
Post-laminectomy syndrome aka Failed back surgery syndrome (FBSS) Post-laminectomy syndrome is a broad term which can include pain localized to the lower lumbar region or the buttocks, persistent radicular pain, or diffuse lower extremity pain. Most published series distinguish between back and leg pain, but seldom define the details of the pain syndromes. SCS is accepted in the treatment of leg pain, but its widespread use for relief of pain in the lower lumbar area still remains to be defined.
A technical challenge has been to provide stimulation in the low back, where paresthesia is often replaced over time by an unpleasant segmental band of stimulation from the thoracic roots. Previous pioneering work by Jay Law 25, 26 has shown that stimulation in the low back can be obtained only if one uses multiple arrays of closely spaced bipolar electrodes at T9-T10. North et al. have shown that one single quadripolar electrode in midline has the ability to stimulate the axial low back. 27 Flanking the cathode by lateral anodes also appears to increase the discomfort threshold theoretically.
28
Marchand et al. 29 conducted a prospective randomized controlled study examining patients with at least one prior surgery for chronic back pain secondary to trauma. Each patient used a SCS and acted as his or her own control.
Although a small trial, with only eight patients, pain scores were significantly reduced with SCS compared to placebo stimulation.
The longitudinal studies by North showed that in patients with post-surgical lumbar arachnoid or epidural fibrosis without surgically remediable lesions, SCS provided at least 50% pain relief in 53% of patients at 2.2 years.
30 North et al. also conducted a study randomizing patients with FBSS to either repeat back surgery or SCS surgery, 33 allowing crossover after six months. Ten of fifteen patients crossed over from back surgery to SCS, while only two of twelve patients crossed over from SCS to back surgery.
Turner et al. 31 systematically reviewed a total of 41 articles from 1966 to 1994 and noted that approximately 50-60% of patients with post-laminectomy greater than 50% pain relief was attained from the use of SCS. In 1996, Burchiel et al. conducted a prospective multicenter study with one year follow-up and also reported 55% successful stimulation.
32
Angina
There are well documented reports in the literature revealing uniformly good results using SCS to relieve anginal pain. [34] [35] [36] [37] [38] Further, the results have been maintained in long term follow-up and have been substantiated by a reduction in the intake of nitrates as well. Interestingly, other findings have supported the evidence that SCS has effects that go beyond pain relief. The observations that there is less ST segment depression and that the exercise capacity, the time to angina and the recovery time all improve with stimulation may suggest that there is a reduction in ischemia. In a positron emission tomography study, a redistribution of myocardial flow in favor of ischemic parts of the myocardium has been demonstrated as a long term effect of spinal cord stimulation, both at rest and after pharmacologic stress induction.
39
Vulink et al. conducted a prospective study on quality of life changes in patients with refractory angina pectoris implanted with SCS. They found that both the pain and the health aspects of quality of life improved significantly after 3 months of SCS. Further, social, mental and physical aspects of quality of life were found improved after one year of SCS.
40
Hautvast et al. 41 implanted SCS in patients with stable angina pectoris and randomized them. One group's remained inactivated while the other group was instructed to use the stimulator three times per day for one hour and with any angina attack. At 6 weeks, compared with controls, the treatment group had increased exercise duration and time to angina, and decreased anginal attacks and sublingual nitrate consumption. Also, observed was a decrease in ischemic episodes on EKG, as well as a decrease in observed ST segment depressions on exercise EKG. There was an increase in perceived quality of life and decrease in pain.
Mannheimer et al. 42 randomized 104 patients accepted for CABG to receive either CABG (n=51) or SCS (n=53) in the ESBY study. This study demonstrated that patients randomized to SCS showed a greater than 30% improvement in Nottingham Health Profile (NHP) scores compared with baseline, which was significant and comparable to the improvement shown by patients randomized to CABG. 43 These results were consistent on follow up after four years. It is important to know that the five-year mortality of 27.9% in the ESBY study was similar between those receiving SCS and those who received CABG, with no difference in the percentage of cardiac deaths. The ESBY study showed that cardiac events were similar across the groups, but that there was significantly more cerebrovascular events observed in the CABG group.
Both groups experienced a significant reduction in both the number of angina attacks and the consumption of nitrates. There was no significant intergroup difference regarding these parameters. In another prospective study of 104 patients who underwent SCS implantation for refractory angina pectoris there was a significant decrease in angina episodes at rest, angina episodes with activity, and total angina episodes 44 DeJongste et al. 36 randomized seventeen patients with angina to an active treatment group (i.e. SCS implantation) and a control group. The control group was followed for two months followed by SCS implantation. Both groups were followed for a total of 12 months. This study also revealed a statistically significant reduction in the incidence of angina attacks and in the consumption of nitrates.
Five additional studies are reported to be prospective but without matched controls. 36, 40, [45] [46] [47] [48] Each of these revealed significant benefit from spinal cord stimulation. The benefit indices ranged from reduction in angina attacks, decrease nitrate consumption, decrease in NYHA grade and improvement in NHP grade. 41 demonstrated no significant changes in heart rate variability after 6 wks, concluding that autonomic modulation of heart rate may not be the mechanism of action. There SCS may reduces myocardial ischemia via homogenization of myocardial blood perfusion.
39,51 SCS can improve lactate metabolism in the heart muscle, and lactate metabolism, oxygen demand and blood flow in the coronary sinus.
52 SCS does not effect variability in heart rates or cardiac arrhythmias. 35, 53, 54 We do not know whether the pain relief is due to direct depression of the nociceptive signals in the spinal cord or whether there is secondary gain from a reduction in the ischemia. 55, 56 Foreman has shown that dorsal column stimulation inhibits the activity of spinothalamic tracts cells evoked by activation of the cardiac sympathetic afferents or by intracardiac bradykinin. 14 On the other hand the stimulation might producing a prolonged inhibition of the hyperactive sympathetic system, as was shown experimentally in the rat by Linderoth et al. 15 The most appropriate electrode location for the treatment of angina pectoris is most likely the lower cervical and upper thoracic region, although some have reported successful higher cervical placements. 42 Another consideration is continuous versus cyclical use of SCS. In practice, patients using SCS for angina pectoris often use a low intensity stimulation for several hours per day for prophylactic purposes. described a patient treated for irritable bowel syndrome who was developing escalating pain and diarrhea. In the first 6 months there was a subjective decrease in pain on a 10-point scale from 9/10 to 2/10, with only two diarrhea episodes and with significant reduction in pain medications. There was some return of pain after ten month follow-up, but still a significant reduction in diarrhea. Khan et al. 62 reported on the largest series with nine patients with refractory abdominal pain, all of whom had a significant improvement in pain scores as well as decreased narcotic use at six to eight month follow up. Tiede et al. described treatment of refractory abdominal pain in two patients. Both patients had a significant history including multiple abdominal surgeries and failed conservative measures. Each patient had an element of postprandial abdominal pain with associated nausea and vomiting. In both patients the leads were placed at the T2 level with significant improvement in pain, decreased narcotic use and increase functioning, such as return to work 63 . Kapur et al. 64 recently described relief of abdominal pain associated with colchicine intolerant or resistant patients with familial Mediterranean fever by placement of the electrodes at the lower thoracic levels.
More recent studies have looked at the treatment of visceral pelvic pain with reference to the dorsal columns and spinal cord stimulation. Kapural et al. 65 reported on the value of neurostimulation for chronic visceral pelvic pain in six female patients with the diagnosis of long-standing pelvic pain. These patients had a history of endometriosis, multiple surgical explorations, and dyspareunia. At an average follow up of 30 months there was a significant decrease in the pain score with an average of more than 50% pain relief, with a decrease in opiate use.
Visceral innervation follows the embryologic origin and location of the viscera and is arranged in viscerotomes, analogous to cutaneous dermatomes. 66 The viscera obtain their innervation via the sympathetic and parasympathetic pathways. The parasympathetics carry their afferents to anterior and posterior vagal trunks and are therefore not as amendable to spinal cord stimulation. The sympathetics carry nociceptive information from the viscera to spinal nerve roots making them a more viable target. The sympathetic afferents in the lower six thoracic and the upper three lumbar spinal segments have been shown to transmit painful impulses from the viscera 67 .
Equipment (Electrodes and pulse generators)
There are various implantable technologies existing for SCS. These include trial percutaneous electrodes, permanent percutaneous electrodes, permanent plate electrodes, totally implantable rechargeable and non-rechargeable pulse generators (IPG) and radiofrequency (RF) driven pulse generators.
Percutaneous electrodes
Percutaneous electrodes can be inserted without much dissection and can easily be removed in the implanting physician's office. During implantation, these electrodes can be advanced over several segments in the epidural space, allowing testing of several spinal cord levels to assess for optimal electrode position.
Contemporary percutaneous electrodes are slim electrodes, only a few millimeters in diameter and containing four or eight contacts (referred to as either quadripolar or octopolar electrodes). Choosing the particular electrode entails deciding how many segments of the spinal cord are to be covered, with larger spacing allowing broader coverage. Alternatively, closer spacing allows better steering and electric field shaping. Additionally, multiple parallel electrodes and different configuration matrices can be constructed which can create extremely focused electrical fields.
Spinal/Functional
Figure 2
The above graphic on the left shows a patient who had an L4,5 and L5,S1 anterior posterior fusion for back and leg pain from lumbar spondylolisthesis. She continued to have both back and leg pain despite a successful lumbar reconstruction. An ANS (Advanced Neuromodulation System) tripole electrode was implanted in the thoracic spine. There are three columns of electrodes. The middle covers the back and the lateral columns provide stimulation into the legs. The electrode was placed in the operating room with fluoroscopy and intra-operative EMG monitoring under general anesthesia.
Plate electrodes
Plate-type electrodes (or ribbon electrodes, paddle electrodes, or laminotomy electrodes) require a surgical procedure, laminotomy, and implantation under direct vision. Implantation under direct vision may be safer in the upper thoracic and cervical areas, where there is a risk of damaging the spinal cord with the large bore Touhy needle. Most implants can be done through a skin incision between 2.5 cm and 4 cm long, depending on the size of the patient and spinal anatomy. The amount of bony removal is usually minimal.
The main advantage of plate electrodes is their greater inherent stability, with less to migrate. Plate electrodes are also more energy efficient. Multiple arrays or different electrode configurations can be constructed with plate electrodes. As with percutaneous leads, there are varying lengths, and shapes-such as curved leads and hinged leads, all designed to help facilitate insertion and tailor the electrode selection to the patient. They are a preferred option in the case of previous spine surgery at the implant levels.
North et al. have published on comparison between plate and percutaneous electrodes.
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Laminectomy electrode placement, although more invasive than percutaneous placement, yielded significantly better clinical results in patients with failed back surgery syndrome at up to 3-year follow up. Clinical success was defined as at least 50% pain relief and patient satisfaction with treatment. Secondary outcome measures were ability to perform various activities of daily living, neurological function, and analgesic use. There is some theoretical evidence that shaping of the electrical field is possible with even more complex electrode arrays. Holsheimer et al. 69 concluded that the transverse tripolar system enabled finer control of paresthesia. Electrical field steering could change the paresthesia area completely. Using transverse tripolar configurations increases the threshold for stimulation of dorsal roots. This results in a wider therapeutic range, wider paresthesia coverage, and a greater probability to fully cover the painful area with paresthesia.
Rechargeable and Non-rechargeable Pulse Generators and RadioFrequency Receivers Electrical stimulation consists of rectangular pulses delivered to the epidural space through implanted electrode via a power source. Two basic types of systems are currently available: an Internal Pulse Generator (IPG; also called the battery) or a radiofrequency (RF) coupled pulse generator with an implantable receiver. The later has largely fallen out of favor due to the inconveniences of having an external power source. However, the advent of the totally implantable, rechargeable pulse generator has surmounted the power requirement issues, which were previously the main RF advantage.
The totally implantable pulse generator contains a lithium battery. Activation and control occur through an external transcutaneous telemetry device. The IPG can be turned on and off through a small controller which the patient can carry. The controller also allows some control over the stimulation parameters. More extensive control of the unit can be achieved through a small portable unit which can be programmed by the physician. Life span of the battery varies with usage and with the utilized parameters (voltage, rate, pulse width, etc.). Most patients can expect that the battery will last from 2.5 to 4.5 years. Available lithium powered pulse generators allow stimulation with fine control of stimulation amplitude, pulse width and rate. Replacement of the battery requires a surgical procedure which is usually performed on an outpatient basis.
Radio frequency (RF) driven systems, consist of a passive receiver, implanted subcutaneously, and a transmitter which is worn externally. An antenna applied to the skin in correspondence of the receiver is connected to the transmitter, which sends the stimulation signals transcutaneously. RF systems have the inconvenience of having to wear the antenna and the radio-receiver, replacing the batteries on a regular basis, and ensuring proper contact of the antenna on the skin. These issues may be critical for individuals with limited upper-limb motor function. Other patients, particularly individuals who have reflex sympathetic dystrophy (RSD), may not tolerate the antenna taped to the skin. However, what one loses in convenience, however, is gained in power and flexibility. Currently only RF systems can provide a stimulation rate up to 1,400 Hz. This might be beneficial in some patients with neuropathic chronic pain syndromes 70 as well as in patients with extrapyramidal motor disorders.
Complications
With the proper expertise, permanent complications are rare. 71 The most serious complications are paralysis or other severe neurological deficits, which are risks inherent in any spine surgery. Infection of the implanted hardware has occurred with a 3-5% rate. Persistent pain at the implant site has been seen in about 5% of patients. Recalcitrant cerebrospinal fluid leakage has been encountered in a few patients, requiring multiple surgical revisions. Breakage or malfunction of the implanted hardware, particularly the electrodes and the subcutaneous extension cables has been encountered in about 10% of the implanted systems. Painful stimulation, necessitating either repositioning or removal of the electrode, has also been reported in a number of cases.
Conclusions
The treatment of chronic pain remains challenging. Spinal cord stimulation has been performed for over 30 years, and slow but steady progress with this technology has been made. As the equipment and stimulation parameters are improved, selection criteria have been better defined and are slowly being expanded. More importantly, experience in the technique and the equipment has made SCS a much more reliable and safe modality. Like all the modalities performed for chronic pain management, its results are favorable. It is important to remember that the goal of neurostimulation is to reduce pain, rather than to eliminate pain. It has been shown to have a 50% improvement in pain relief, and reduce the use of more medications Very few other invasive modalities can claim this success rate with a few years of follow-up.
Careful follow-up of the patients is necessary for successful long-term satisfaction. Equipment related problems can arise at any time after implantation, such as discomfort at the pulse generator/radio receiver site, electrode breakage or migration, infection, etc., and an open dialogue with the patients is vital for the continuing successful implementation of the modality. Spinal cord stimulation has earned a well established and firm role in contemporary chronic pain management. The management of acute ischemic stroke has been recognized as a significant medical problem. Stroke remains to be the third leading cause of death and the leading cause of long-term disability; 80% of all strokes are ischemic (a blood clot disrupts blood flow), and the rest are hemorrhagic (a blood vessel ruptures in the brain). Nearly 1 in 15 deaths in 2003 were the result of a stroke.
1
Approximately 750,000 new strokes occur annually, of which 250,000 result in the deaths in the United States alone. The latest estimates for stroke costs total to about $30 billion in direct costs, and $20 billion are in indirect costs.
2 If nothing is done about this disease, the annual incidence of strokes is expected to reach 1.1 million by the year 2015.
Despite recent advances in its diagnosis and treatment, a population of the general public still have difficulty recognizing stroke symptoms, and are unaware that stroke is indeed a medical emergency. The two major causes of delay in treatment are mainly failure to appropriately recognize the symptoms that indicate stroke (numbness, dizziness, confusion, or headache), and failure to access a medical facility that is equipped to handle acute strokes. In an effort to raise awareness, and the level of care provided to stroke patients, stroke center standards were created and hospitals that met the strict criteria were then selected. However, many hospitals do not have the necessary infrastructure and organization needed to triage and treat patients with stroke rapidly and efficiently. 4 Seeing that the model of trauma centers were effective both in the rural and urban settings, the concept of acute stroke centers were then explored. The Brain Attack Coalition, which is a multidisciplinary group involved in stroke care, set out to establish guidelines for stroke centers. The role of a Primary Stroke Center is to be able to stabilize and provide emergency care for the acute stroke patients. Depending on the complexity of the case, they would either admit the patient, or transfer them to a comprehensive stroke center. On the other hand, the Comprehensive Stroke Center should be able to provide complete care to any complex patient; they should have the necessary infrastructure, both in personnel and equipment.
The main goals and benefits of a certified stroke center are the following:
• Improve the efficiency of patient care • Provide access to the most up to date stroke therapies, which ultimately will lead to fewer peristroke complications • Increase the number of patients discharged home than to skilled nursing facilities • Decrease the length of hospital stay.
By accomplishing all of the above, the cost to the healthcare system will be reduced, and hopefully, patient satisfaction should also increase.
Although advances in stroke treatment have moved forward over the past years, the main limitation remains to be the prompt and proper treatment. Thrombolytic therapy, which has been FDA approved for over 10 years now remains to be the mainstay of acute treatment, however, only about 3% of patients with acute strokes are being treated. Another important goal of stroke centers is to provide access to these acute therapies.
The Brain Attack Coalition and American Stroke association have developed a framework of requirements needed to establish a Primary Stroke Center. These elements are based on the use of standardized method of delivering evidence based clinical care with known improvement of patient outcome. The Joint Commission has recognized the effectiveness of these measures and has based their criteria for Primary Stroke Center Certification on the recommendations listed in the accompanying table. [6] [7] [8] In this decade, the integration of multidisciplinary approach in the treatment of strokes will occur within the structure of a stroke center. Establishing a Stroke Center requires coordination of efforts throughout the Health System. Even hospitals with limited resources can positively impact the outcome of a stroke patient. Smaller healthcare centers can develop a "Stroke Network" with larger healthcare centers to provide comprehensive care. The most crucial component of stroke care is time-"Lost time equals lost brain" is the slogan, as brain damage progresses the blood flow is cut off. Rapid evaluation and referral with "Treat and Transfer" protocols can be established at any hospital that has the ability to provide Emergency Services. With new therapies emerging for stroke treatment, this could significantly impact all patients having access to cutting edge stroke care.
The American Heart Association's Performance Awards for hospitals is based on 85% compliance for patients in each of the following items. The Silver Award is given to institutions who meet goals for 12 months and the Gold Award, for 24 months.
• Percent of acute ischemic stroke patients who arrive at the ED within 120 minutes (two hours) of onset of stroke symptoms who receive IV t-PA within 180 minutes (three hours) of onset of stroke symptoms
• Percent of ischemic stroke or TIA patients who receive antithrombotic medication within 48 hours of hospitalization
• Percent of ischemic stroke or TIA patients discharged on antithrombotics (e.g., warfarin, aspirin, other antiplatelet drug)
• Percent of ischemic stroke or TIA patients with atrial fibrillation who are discharged on anticoagulation therapy (warfarin/Coumadin or heparin/heparinoids) unless an absolute or relative contraindication exists
• Percent of patients at risk for DVT who received DVT prophylaxis by the second hospital day
• Percent of ischemic stroke or TIA patients with LDL >= 100 mg/dL OR on cholesterol reducer prior to admission who are discharged on cholesterol reducing drugs
• Percent of smokers who receive smoking cessation advice or medication (e.g., Nicoderm or Zyban) at discharge
These steps are all based on published evidence assessing modifiable risk factors which affect the likelihood of stroke.
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Any one of these risk factors can double the chance of a stroke recurring.
Acute Stroke Team
This is composed of physicians and health care professionals with experience and proper training in management of acute strokes. They should be available 24 hrs a day to evaluate patients with symptoms suggestive of an acute stroke. The institution should have a Stroke notification system in place with documented expected response times.
Written Care Protocols
One of the major key elements in developing good outcomes is through the implementation of protocols. As such, protocols should be based on well established Standards of Care and national guidelines. This should include emergency care of ischemic/hemorrhagic stroke patients. Studies have shown that by adhering to protocol guidelines, more patients were properly screened for tPA. Not only was there a substantial increase in the proportion of patients receiving thrombolytic therapy, but rather, there was also a decrease in the rates of symptomatic ICH. 5 If the patient is deemed to be complex, a protocol should be in place for those requiring transfers to a comprehensive center-a "Treat and Transfer" pathway should be initiated.
Emergency Department
The ED serves as the gateway between the patient and the hospital. It is important that emergency personnel are trained in recognizing, diagnosing, and treating all types of acute stroke. There should be highly organized means communication amongst the EMS, ED personnel and the Acute Stroke Team. The ED should be able to provide proper documentation of patient's history, procedures, and qualifications for thrombolytic therapy.
Stroke Unit
This is a dedicated unit staffed by health care personnel (vascular neurologists, stroke-trained nurses, physical/occupational/speech therapists, case managers, social workers) who are trained to care for patients with cerebrovascular diseases. This unit should also be equipped with infrastructure such as continuous telemetry, and the capability for blood pressure monitoring. There has been a big difference noted in the care received by stroke patients in the stroke unit setting as compared to the general medical floors. Patients in stroke units had an 8% reduction in length of stay, and 7% increase in going back to living at home, and a 17% reduction in death rates. The cost of forming and operating stroke units will vary depending on size and location. Again, there is a need for written care protocols for standardization of care.
Neurosurgery
During the acute phase of a stroke, patients may need a neurosurgical procedure, thus, a primary stroke center must be able to provide neurosurgical care within 2 hours if clinically necessary. If this is not met, the patient should be transferred to a medical facility with an available neurosurgeon who is experienced in treating different types of acute strokes. A protocol is necessary to Treat and Transfer patients with the need for comprehensive stroke care.
Neuroimaging
In order to have a proper stroke diagnosis, it is vital for a primary stroke center to have imaging capability 24 hours a day. The ideal door to imaging time is within 25 minutes of order entry, and must be interpreted within 20 minutes.
Hospital and Administrative Support
There should be a designated Medical Director of Stroke Center with expertise and training in Cerebovascular Diseases. Com mit ment f rom ad mi nist rat ion of hospital/health system is important in providing support and funding for the needed resources to maintain the ability to deliver high quality and efficient care to acute stroke patients and the community.
Laboratory Services
This should be available 24 hrs. a day (CBC, Chemistry and Coagulation studies) The chest x-ray and EKG must be completed within 45 minutes of patient's arrival Outcome/Performance Improvement: Primary Stroke Centers must be able to develop specific stroke performance measures to be monitored by Performance Improvement Department, there should be ongoing efforts with Stroke Team and Performance Improvement to improve stroke care by utilizing benchmarking and performance measures data
Educational Programs
In order to keep up with new developments in stroke care, the stroke team professional staff is required to maintain 8 hours CME (or its equivalent) credits per year. In addition to this, the stroke center should be able to offer education to the community at least twice a year in relation to Stroke recognition, prevention, and treatment.
Endovascular Cure of a "Locked-In" Patient
We report the case of a 60 year-old right-handed gentleman who became acutely "Locked-In" several days after a lower extremity orthopedic procedure. He underwent emergent endovascular treatment and had complete resolution of his neurologic findings except for mild dysarthria and dysphagia. Endovascular intervention for posterior circulation thrombosis is highly effective when patients are treated within 24 hours.
Case
FC is a 60 year-old right-handed gentleman that underwent uncomplicated total knee arthroplasty and was started on low dose warfarin therapy for deep venous thrombosis prophylaxis. On postoperative day number two the patient had an acute change in his neurologic status. A computed-tomography scan of his head was obtained showing a hyperdense basilar artery. He was emergently transferred to our institution.
On arrival the patient was lethargic but able to follow commands with eye blinks only. His pupils were equal and reactive but he only had vertical gaze. The right extremity minimally withdrew to stimulation. Computed-tomography angiogram of the head showed a dominant right vertebral artery with occlusion just distal to the posterior inferior cerebellar artery origin extending to just below the superior cerebellar arteries.
The patient was taken emergently to the Endovascular Neurosurgery Suite and the right femoral artery accessed. The right vertebral artery was selectively catheterized and digital subtraction angiography performed revealing complete occlusion of the right vertebrobasilar junction without distal runoff or PCA filling. A Hyperglide balloon was positioned at the VB junction and seven inflations were performed, revealing a focal stenosis at the junction. A Gateway 4 balloon was positioned next and inflated to six atmospheres of pressure. Subsequent angiographic runs revealed complete resolution of the thrombus and filling of both PCAs and SCAs, as well as the basilar perforators. A Wingspan 4x5x20 stent was then deployed at the location of the stenosis resulting in complete resolution of the stenosis and thrombus. Additional angiographic runs showed distal occlusions bilaterally in the P4 segments; these were treated by placing an SL-10 microcatheter in the P4 segments and injecting 150,000 units of Urokinase on the right and 200,000 units on the left.
Post-procedurally the patient remained intubated for less than twenty-four hours. His neurologic exam improved to normal except for mild dysarthria and dysphagia and a right upper extremity drift without associated weakness. Magnetic resonance imaging of his brain revealed acute infarcts in the left pons, right occipital lobe, right dentate nucleus, both mesial temporal lobes, and the right posterolateral thalamus. He was gradually mobilized with the assistance of physical therapy/ occupational therapy and eventually discharged in good condition. 
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reported. However, we recommend treating up to 24 hours post-ictus only. An additional study reviewed outcome predictors for basilar artery thrombosis and found that recanalization after thrombolysis and low NIH stroke scale at admission were associated with a favorable outcome; initiating thrombolysis early after ictus as well CT evidence of a hyperdense basilar artery were positively associated with recanalization rates. 3 "Locked-In" Syndrome resulting from acute basilar artery thrombosis is curable but requires the patient be quickly diagnosed and transferred expeditiously to a specialized center with a highly experienced endovascular neurosurgical team. 
Introduction
Epidural anesthesia is a procedure which is well tolerated and has a low incidence of adverse events. In performing caesarean sections, regional anesthesia (spinal or epidural) is the preferred modality for anesthetic delivery 7 . Although rare with continuous epidural anesthesia, epidural hematomas have been reported to occur with an incidence between 1:150,000 and 1:190,000
10 . An underlying bleeding diathesis has been implicated as a causative factor. We present the sixth reported case of hemorrhage into an occult intradural neoplasm after spinal or epidural anesthesia. Similar lesions have not been reported in the recent spine literature. 1, 2, 3, 5, 8 Case Report
A 27-year-old gravida 1, para 0 patient underwent a Caesarean section with epidural anesthesia without difficulty. She was discharged home with a healthy infant on post operative day two. Three days after the procedure the patient noted a moderate degree of low back pain, which was initially attributed to ligamentous strain. Conservatively therapy, consisting of bed rest and analgesics, failed to provide symptomatic relief. The symptoms persisted and the patient progressed over the following three weeks, noting worsening low back pain radiating to the legs. The patient then presented to the emergency department, where she described severe low back pain radiating into both lower extremities. Her past medical history was insignificant. She denied any history of coagulopathy, heavy menses or any contributory family history. A thorough neurological exam revealed intact motor strength sensation, with normal deep tendon reflexes and an absent Babinski's sign. A rectal exam revealed normal anal sphincter tone and volition.
Investigations
No hematological abnormalities were noted on laboratory examination. MR Imaging of the lumbar spine with and without gadolinium revealed an oblong intradural mass at T12-L1 with intense peripheral enhancement and irregular central nonenhancement was noted (Figures 1-3) . Complete MR imaging of the neuroaxis showed no additional lesions. 
Treatment
The patient underwent a T12 to L2 laminectomy. Intraoperatively, an intradural mass adherent to the cauda equina and filum terminale with some intratumoral hemorrhage was removed. A gross total resection was accomplished.
Pathology
Final pathologic analysis of the surgical specimen revealed a myxopapillary ependymoma.
Postoperative Course
The patient made a full recovery. She manifested initial urinary retention, which resolved with the discontinuation of narcotics. Postoperative MR Imaging revealed no evidence of residual tumor.
Discussion
Extramedullary spinal cord tumors may be intradural, extradural, or a combination of the two. Extradural tumors account for roughly 30% of spinal cord neoplasms while intradural extramedullary tumors are responsible for approximately 40 to 50%. 4 Intradural spinal cord tumors are uncommon with an incidence of about 3-10 per 100,000 individuals. These tumors occur predominately in the third and fourth decades of life. 9 The most common extramedullary spinal cord tumors are nerve sheath tumors, meningiomas and filum terminale ependymomas. Ependymomas are the most common gliomas of the lower cord, conus and filum terminale; the myxopapillary histological variant is most common. Approximately 40% of all spinal ependymomas arise within the proximal intradural filum terminale. 4 Back pain is the most common presenting symptom, with neurological compromise rare secondary to the adaptive compressibility of the surrounding structures. Mork and Loken report that in 82% of patients with spinal ependymoma, symptoms were present for more than 1 year before the diagnosis was achieved.
6 Treatment for these lesions is typically en bloc surgical resection.
9 Radiation therapy is reserved for recurrent disease or aggressive histopathology, with regular radiographic follow-up recommended. In cases of subtotal resection, radiotherapy may be required.
Epidural anesthesia is an effective procedure with a low incidence of complications. Neurological compromise following epidural anesthesia, while highly uncommon, is the most concerning potential sequela of the procedure. Epidural hematomas may rarely occur during continuous epidural anesthesia, with a reported incidence between 1:150,000 and 1:190,000. 10 The majority of these cases are believed due to a primary coagulopathy.
Rarely, hemorrhage from an occult spinal mass occurs in an asymptomatic patient receiving epidural anesthesia. The first case of intratumoral bleeding in an asymptomatic patient after attempted epidural anesthesia was reported in 1984. A patient developed low back pain, bladder dysfunction, worsening motor and sensory function in both legs three days after epidural analgesia.
8 Since then, four additional cases involving hemorrhage into an occult neoplasm by regional lumbar spine anesthesia have been reported. Three cases involve epidural anesthesia 1,3,5 and one was caused by a subarachnoid injection of anesthetic.
2 In each of these cases, the underlying lesion was an ependymoma. In our case and one other the only complaint prior to neurosurgical intervention was severe low back pain with increasing bilateral radicular showing the intradural mass. The entire spinal canal is occupied by the heterogeneously contrast enhancing mass.
pain. 5 In the remaining reports, a component of lower extremity weakness and bowel or bladder dysfunction was noted. More severe presentations are reported: Jaeger et al. detailed a similar case with a lesion in a comparable area and described neurological deficits progressing to paraplegia within 24 hours.
3 Previously reported cases are reviewed in Table 1 .
Conclusion
Occult spinal masses should be considered in the differential diagnosis in a patient with new onset neurological deficits or unusual pain complaints after spinal or epidural anesthesia. MR imaging of the lower thoracic and lumbar spine may be useful in evaluation of these symptoms. 
Materials and Methods
This study is a case report identifying Magnetic resonance imaging artifact associated with the use of Neuroform stents. Data was collected from the patient's chart, operative report, and imaging studies.
Case Report
The patient presented in this report is a 55 year old right handed female who underwent screening MRA of the head due to a family history of subarachnoid hemorrhage. This revealed a 5 mm left carotid wall aneurysm. Subsequently, cerebral angiography revealed a broad based 6 mm by 4 mm left posterior carotid wall aneurysm (Figure 1 ). The angioarchitecture of the aneurysm made it necessary to place a stent in order to prevent coil prolapse into the parent vessel.
Due to technical difficulty associated with the tortuousity of the vessel, a Neuroform-3 stent was prematurely deployed into the lacerum portion of the left internal carotid artery (ICA). However, another neuroform-3 stent was able to be placed across the neck of the posterior carotid wall aneurysm. Postoperatively, the patient remained neurologically intact and was maintained on plavix therapy to prevent thromboembolic events. We allowed the stent to adhere to the vessel over a period of eight weeks at which time the patient underwent coil embolization of the aneurysm without any complications (Figure 2 ).
Four weeks post coiling, the patient presented to the emergency room complaining of right sided numbness and tingling. A computed tomographic (CT) scan of the head was unrevealing of any pathology. An MRI/A of the neck and head was performed to delineate whether a carotid dissection with associated thromboembolic event was the causation for the patient's symptoms ( Figure  3 ). This revealed a change in the caliber of the left ICA at the level of the petrous carotid. While certainly this could represent susceptibility artifact from the deployed stent, no such cases have been reported in the English literature. Thus the above mentioned imaging results led to the patient being admitted to the hospital and subsequent prophylactic anticoagulation. A CTA of the head was performed to better understand the exact location and length of the dissected segment of vessel ( Figure 4 ). Due to the surrounding bone associated with the petrous carotid artery, the CTA was not revealing in delineating whether the MRA findings represented artifact or actual vascular dissection. Thus it was essential to perform cerebral angiography which revealed no evidence of dissection or recurrence of the previously coiled aneurysm ( Figure 5 ).
Discussion
Use of self expanding Nitinol stents has revolutionized the treatment of intracranial aneurysms as well as intracranial atherosclerotic disease. MRI/A have been shown to be of great value in evaluating restenosis of a treated vessel or recanalization of treated aneurysms where these stents have been utilized. A multitude of reports in the English literature have revealed that MRI/A creates minimal artifact when imaging vessels with these stents. In fact, there are no reports of MRA associated signal drop out from imaging of vessels which have been stented with Neuroform stents.
Our case report exemplifies that MRA imaging can indeed create a signal drop out at the site of Neuroform stent placement thus creating a false image of possible dissection of the vessel. Such an artifact can lead to further treatments and imaging which not only increase the cost burden to society but also can increase the morbidity to the patient. While we did perform a computed tomographic angiography (CTA) of the head, it was of no value as the artifact from the petrous bone prevented a clear delineation of whether a dissection existed or not. 
